Sanjay Shrivastava serves as Executive at Hancock Jaffe Laboratories, Inc., where they oversee executive responsibilities. Since joining the company, Sanjay Shrivastava has executed 4 insider transactions totaling $3.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2022 involved purchasing 1,000 shares valued at $3.9K.
Sanjay Shrivastava currently holds 3,888 shares of Hancock Jaffe Laboratories, Inc. (HJLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanjay Shrivastava has been a net buyer of HJLI stock. They have purchased $3.9K and sold $0 worth of shares.
Sanjay Shrivastava's most recent insider trade was on Jun 30, 2022, when they purchased 1,000 shares at $3.85 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 18, 2020 | HJLI | $0 | Award | 62,500 | $N/A | Discretionary |
| Nov 27, 2018 | HJLI | $75.0K | Award | 29,183 | $2.57 | Discretionary |